Main UU connection: Emeritus professor regulatory science and pharmaceutical policy
Other functions: Member Senate and Exco European Federation for Pharmaceutical Sciences (EUFEPS), Visiting professor Faculdade de Farmácia da Universidade de Lisboa and the Copenhagen Centre for Regulatory Science (CORS), Leaderschip Team Lygature, Chairman Scientific Advisory Board Diabetes Foundation, Chairman GGG Council, ZonMw, Member Scientific Advisory Board Dutch Heart Foundation, Member Scientific Advisory Board LACDR, Leiden, Member Advisory Committee Innovative Treatments Covid-19, Ministry of Health.
Research Keywords: regulatory science, pharmacoepidemiology, innovation science, pharmacovigilance, pharmaceutical policy analysis, orphan diseases
Theme: cardiovascular, CNS, cancer
Offering: methodologically innovative approach for regulatory science, broad experienced and informed network on the interface between drug development, regulation and actual drug usage.
Looking for: relevant research questions to apply these methods
|
Education and Experience |
|
|
2017-2020 |
Professor of regulatory science and pharmaceutical policy, Utrecht University |
|
2008-2020 |
Scientific Director Utrecht Collaborating Centre for Pharmaceutical Policy and Regulation |
|
2007-2017 |
Chairman of the Dutch Medicines Evaluation Board (MEB) |
|
2006-2017 |
Several regulatory roles EMA London (e.g. CHMP, PhV Working Party) |
|
1997-2017 |
Professor of pharmacoepidemiology, Utrecht University |
|
1987-1991 |
PhD 'Pharmacy records in pharmacoepidemiology: studies on antiinflammatory and antirheumatic drugs', Utrecht University |
|
1985 |
Fulbright Fellow at the University of Minneapolis, US |
Leeropdracht
Regulatory Science and Pharmaceutical Policy